GlassScriptPhysician profile
Tracy A Casas
NPI 1760904676
$3,605.92
in general payments reported to CMS, 2019-2025
42 companies · $1,278 in 2025
The $1,278 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.04 · 2022: $175 · 2023: $942 · 2024: $1,116 · 2025: $1,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,586 · Travel and Lodging: $350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $350 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,586.19 |
| Travel and Lodging | $350.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $350.00 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $1,080.78 | 2022-2023 | Gammatile |
| Bayer Healthcare Pharmaceuticals INC. | $337.18 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $329.83 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $237.98 | 2024-2025 | Imfinzi, Calquence, Enhertu |
| Janssen Biotech, INC. | $157.49 | 2024-2025 | Darzalex, Tecvayli, Rybrevant |
| Incyte Corporation | $141.69 | 2024-2025 | Jakafi, Monjuvi |
| Merck Sharp & Dohme LLC | $130.87 | 2024-2025 | Keytruda, Welireg, Reblozyl |
| Daiichi Sankyo INC. | $91.62 | 2024-2025 | Enhertu, Datroway |
| Bard Peripheral Vascular, INC. | $79.86 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $79.43 | 2025 | Libtayo |
| Aveo Pharmaceuticals, INC. | $78.87 | 2024-2025 | |
| Legend Biotech USA INC. | $70.76 | 2025 | Carvykti |
| Geron Corporation | $65.77 | 2025 | Rytelo |
| Sobi, INC | $63.77 | 2024-2025 | |
| Eisai INC. | $55.09 | 2024 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $41.08 | 2025 | Orgovyx |
| Lilly USA, LLC | $39.10 | 2024 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $30.43 | 2025 | Iclusig |
| Novocure INC. | $29.98 | 2025 | Optune Lua (Novottf-200t) |
| Stemline Therapeutics INC. | $28.29 | 2025 | Orserdu |
| Immunocore Limited | $25.21 | 2025 | Kimmtrak |
| Emd Serono, INC. | $24.99 | 2024 | |
| Taiho Oncology, INC. | $23.96 | 2025 | |
| Elekta, INC. | $23.07 | 2025 | Elekta Medical Linear Accelerator |
| Azurity Pharmaceuticals, INC. | $23.00 | 2024 | Vivimusta |
| Fennec Pharmaceuticals, INC. | $22.97 | 2025 | Fyarro |
| Alexion Pharmaceuticals, INC. | $22.95 | 2024 | Ultomiris |
| Pharmaessentia USA Corporation | $22.71 | 2025 | Besremi |
| Astellas Pharma US INC | $21.23 | 2025 | Xtandi |
| Adc Therapeutics America, INC. | $21.22 | 2025 | |
| Abbvie INC. | $20.61 | 2025 | |
| Siemens Medical Solutions USA, INC. | $19.84 | 2022 | |
| Spectrum Pharmaceuticals INC. | $19.01 | 2025 | Rolvedon |
| Cardinal Health 414 LLC | $18.86 | 2025 | |
| Boston Scientific Corporation | $17.17 | 2025 | Spaceoar Vue System - 10ml |
| Teleflex LLC | $16.86 | 2025 | Barrigel |
| Caris Mpi, INC. | $16.63 | 2025 | Mi Cancer Seek |
| Kyowa Kirin, INC. | $16.38 | 2024 | Poteligeo |
| Medtronic, INC. | $15.18 | 2021 | |
| Genzyme Corporation | $15.09 | 2024 | |
| Puma Biotechnology, INC. | $14.57 | 2025 | |
| Bioprotect Medical, INC. | $14.54 | 2025 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Casas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.